|
1
|
Little EG and Eide MJ: Update on the
current state of melanoma incidence. Dermatol Clin. 30:355–361.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eggen CAM, Durgaram VVL, van Doorn R, Mooi
WJ, Pardo LM, Pasmans SGMA and Hollestein LM: Incidence and
relative survival of melanoma in children and adolescents in the
Netherlands, 1989–2013. J Eur Acad Dermatol Venereol. 32:956–961.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aung PP, Nagarajan P and Prieto VG:
Regression in primary cutaneous melanoma: Etiopathogenesis and
clinical significance. Lab Invest. Feb 27–2017.(Epub ahead of
print). doi: 10.1038/labinvest.201. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lorigan JG, Wallace S and Mavligit GM: The
prevalence and location of metastases from ocular melanoma: Imaging
study in 110 patients. AJR Am J Roentgenol. 157:1279–1281. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang M, Jiang P, An Z, Baranov E, Li L,
Hasegawa S, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR and
Hoffman RM: Genetically fluorescent melanoma bone and organ
metastasis models. Clin Cancer Res. 5:3549–3559. 1999.PubMed/NCBI
|
|
6
|
Seifert H, Hirata E, Gore M, Khabra K,
Messiou C, Larkin J and Sahai E: Extrinsic factors can mediate
resistance to BRAF inhibition in central nervous system melanoma
metastases. Pigment Cell Melanoma Res. 29:92–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bedikian AY, Papadopoulos NE, Kim KB,
Vardeleon A, Smith T, Lu B and Deitcher SR: A pilot study with
vincristine sulfate liposome infusion in patients with metastatic
melanoma. Melanoma Res. 18:400–404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elder DE: Pathology of melanoma. Surg
Oncol Clin N Am. 24:229–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amann VC, Ramelyte E, Thurneysen S,
Pitocco R, Bentele-Jaberg N, Goldinger SM, Dummer R and Mangana J:
Developments in targeted therapy in melanoma. Eur J Surg Oncol.
43:581–593. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mao G, Jin J, Kunapuli SP and Rao AK:
Nuclear factor-κB regulates expression of platelet phospholipase
C-beta2 (PLCB2). Thromb Haemost. 116:931–940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suire S, Lecureuil C, Anderson KE,
Damoulakis G, Niewczas I, Davidson K, Guillou H, Pan D, Jonathan
Clark, Phillip T Hawkins and Stephens L: GPCR activation of Ras and
PI3Kc in neutrophils depends on PLCb2/b3 and the RasGEF RasGRP4.
EMBO J. 31:3118–3129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen G, Wang Y, Wang L and Xu W:
Identifying prognostic biomarkers based on aberrant DNA methylation
in kidney renal clear cell carcinoma. Oncotarget. 8:5268–5280.
2017.PubMed/NCBI
|
|
13
|
Zekri AR, Hassan ZK, Bahnassy AA, Khaled
HM, El-Rouby MN, Haggag RM and Abu-Taleb FM: Differentially
expressed genes in metastatic advanced Egyptian bladder cancer.
Asian Pac J Cancer Prev. 16:3543–3549. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Collisson EA, De A, Suzuki H, Gambhir SS
and Kolodney MS: Treatment of metastatic melanoma with an orally
available inhibitor of the Ras-Raf-MAPK cascade. Cancer Res.
63:5669–5673. 2003.PubMed/NCBI
|
|
15
|
Poenitzsch Strong AM, Setaluri V and
Spiegelman VS: MicroRNA-340 as a modulator of RAS-RAF-MAPK
signaling in melanoma. Arch Biochem Biophys. 563:118–124. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barault L, Veyrie N, Jooste V, Lecorre D,
Chapusot C, Ferraz JM, Lièvre A, Cortet M, Bouvier AM, Rat P, et
al: Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH
kinase) signaling network correlate with poor survival in a
population-based series of colon cancers. Int J Cancer.
122:2255–2259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li XJ, Li B, Huang JS, Shi JM, Wang P, Fan
W and Zhou YL: Effects of acrylonitrile on lymphocyte lipid rafts
and RAS/RAF/MAPK/ERK signaling pathways. Genet Mol Res.
13:7747–7756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wilson BJ, Saab KR, Ma J, Schatton T, Pütz
P, Zhan Q, Murphy GF, Gasser M, Waaga-Gasser AM, Frank NY and Frank
MH: ABCB5 maintains melanoma-initiating cells through a
proinflammatory cytokine signaling circuit. Cancer Res.
74:4196–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao X, Wang X and Zhang S: Bioinformatics
identification of crucial genes and pathways associated with
hepatocellular carcinoma. Biosci Rep. 38:2018. View Article : Google Scholar
|
|
21
|
Qin J, Fang N, Lou J, Zhang W, Xu S, Liu
H, Fang Q, Wang Z, Liu J, Men X, et al: TRB3 is involved in free
fatty acid-induced INS-1-derived cell apoptosis via the protein
kinase C delta pathway. PLoS One. 9:e960892014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mohan N, Ai W, Chakrabarti M, Banik NL and
Ray SK: KLF4 overexpression and apigenin treatment down regulated
anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to
control growth of human malignant neuroblastoma SK-N-DZ and IMR-32
cells. Mol Oncol. 7:464–474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Flores-Fernandez R, Blanco-Favela F,
Fuentes-Panana EM, Chavez-Sanchez L, Gorocica-Rosete P and
Chávez-Rueda AK: Prolactin rescues immature B-cells from apoptosis
induced by B-cell receptor cross-linking. J Immunol Res.
2016:32190172016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang XD, Wu Q and Yang SH: Ferulic acid
promoting apoptosis in human osteosarcoma cell lines. Pak J Med
Sci. 33:127–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao L, Gu H, Chang J, Wu J, Wang D, Chen
S, Yang X and Qian B: MicroRNA-383 regulates the apoptosis of tumor
cells through targeting Gadd45g. PLoS One. 9:e1104722014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Queirolo P and Spagnolo F: BRAF plus
MEK-targeted drugs: a new standard of treatment for BRAF-mutant
advanced melanoma. Cancer Metastasis Rev. 36:35–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahn A, Chatterjee A and Eccles MR: The
slow cycling phenotype: A growing problem for treatment resistance
in melanoma. Mol Cancer Ther. 16:1002–1009. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang S, Tang L, Lin J, Shen Z, Yao Y, Wang
W, Tao S, Gu C, Ma J, Xie Y and Liu Y: ABCB5 promotes melanoma
metastasis through enhancing NF-κB p65 protein stability. Biochem
Biophys Res Commun. 492:18–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao J, Yao X, Tian T, Fu X, Wang W, Li S,
Shi T, Suo A, Ruan Z, Guo H, et al: ABCB5-ZEB1 axis promotes
invasion and metastasis in breast cancer cells. Oncol Res.
25:305–316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chong CC, Cheung ST, Cheung YS, Chan AW,
Chan SL, Yu SC and Lai PB: Novel biomarkers GEP/ABCB5 regulate
response to adjuvant transarterial chemoembolization after curative
hepatectomy for hepatocellular carcinoma. Hepatobiliary Pancreat
Dis Int. 17:524–530. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grimm M, Krimmel M, Polligkeit J,
Alexander D, Munz A, Kluba S, Keutel C, Hoffmann J, Reinert S and
Hoefert S: ABCB5 expression and cancer stem cell hypothesis in oral
squamous cell carcinoma. Eur J Cancer. 48:3186–3197. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo Q, Grimmig T, Gonzalez G,
Giobbie-Hurder A, Berg G, Carr N, Wilson BJ, Banerjee P, Ma J, Gold
JS, et al: ATP-binding cassette member B5 (ABCB5) promotes tumor
cell invasiveness in human colorectal cancer. J Biol Chem.
293:11166–11178. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Cheng Q, Yin H and Yang G:
Regulation of autophagy and EMT by the interplay between p53 and
RAS during cancer progression (Review). Int J Oncol. 51:18–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yousefi H, Karimi P, Alihemmati A, Alipour
MR, Habibi P and Ahmadiasl N: Therapeutic potential of genistein in
ovariectomy-induced pancreatic injury in diabetic rats: The
regulation of MAPK pathway and apoptosis. Iran J Basic Med Sci.
20:1009–1015. 2017.PubMed/NCBI
|
|
36
|
Ritt DA, Abreu-Blanco MT, Bindu L, Durrant
DE, Zhou M, Specht SI, Stephen AG, Holderfield M and Morrison DK:
Inhibition of Ras/Raf/MEK/ERK pathway signaling by a stress-induced
phospho-regulatory circuit. Mol Cell. 64:875–887. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han YF, Ji LH, Feng TT, Liu F, Cui S and
Su J: Effect of ERK1/2 signaling pathway inhibitor PD98059 on the
expression of ras, BRaf, MEK, ERK1/2 in marrow nucleated red blood
cells of CMS Patients. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
25:1571–1575, (In Chinese). PubMed/NCBI
|
